Oxipit to preview first autonomous AI medical imaging application at ECR

Over 300 Total Lots Up For Auction at One Location - MN 04/19

Oxipit to preview first autonomous AI medical imaging application at ECR

Press releases may be edited for formatting or style | March 02, 2021 Artificial Intelligence X-Ray
The AI medical imaging company will showcase the first autonomous AI diagnostics application for healthy patient report automation. The new product by Oxipit automatically identifies chest X-ray images with no abnormality and produces finalized patient reports without any intervention from the radiologist. The application is pending CE mark certification and will be made available for commercial deployments in the Q3 2021.

"Automation of radiology is no longer a promise - it is finally here. It combines our long-term research with firsthand feedback from medical institutions on how AI diagnostics can benefit daily medical practice. We are excited to be the pioneers in the autonomous AI diagnostics field and strongly believe autonomous products will finally boost AI clinical adoption" - notes CEO of Oxipit Gediminas Peksys.

The new AI application will only produce automated reports for chest X-rays, where it is highly confident that the images feature no abnormalities. This allows the sensitivity metric to be higher than 99%. The application is validated using a 500.000 X-ray dataset from multiple medical institutions where Oxipit AI products are currently deployed. Depending on the type of medical institution, the platform can autonomously report on up to 15% of the daily radiologist's workflow.

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

"Initially this would be most helpful for primary care and diagnostics centers, where up to 80% of all chest X-rays feature no abnormalities. Furthermore, a similar autonomy framework can be adapted for large scale screening projects, such as the global tuberculosis effort" - adds Mr Peksys.

The new application builds upon the foundation of Oxipit ChestEye, an earlier Oxipit platform for preliminary chest X-ray reports. Oxipit ChestEye can identify 75 radiological findings - approx. 90% of abnormalities encountered by radiologists on a daily basis.

"Supporting this vast library of radiological findings enables us to rule out any pathologies with high confidence and achieve zero false negative cases across our pilot product deployment sites" - says Mr Peksys.


About Oxipit
Oxipit is a computer vision software startup specialized in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice. Oxipit are the authors of CE certified multi-award winning ChestEye radiology imaging suite.

Back to HCB News

You Must Be Logged In To Post A Comment